Long-term therapy with nucleoside/nucleotide analogues for chronic hepatitis B in Asian patients

Keyphrases

• Chronic Hepatitis B 100%
• Long-term Treatment 100%
• Asian Patients 100%
• Nucleoside Analogues 100%
• Nucleosides 100%
• Tenofovir 66%
• Entecavir 66%
• Chronic Hepatitis B Patients 66%
• Hepatocellular Carcinoma 33%
• High Risk 33%
• Clinically Significant 33%
• Cirrhosis 33%
• Antiretroviral Therapy 33%
• Liver Function 33%
• Liver Histology 33%
• Long-term Management 33%
• Oral Therapy 33%
• Caucasian Patients 33%
• Life Studies 33%
• Compensated Advanced Chronic Liver Disease (cACLD) 33%
• Virological Suppression 33%
• Evidence-based Decision Making 33%
• Decision Choices 33%

Medicine and Dentistry

• Chronic Hepatitis B 100%
• Nucleoside 100%
• Tenofovir 40%
• Entecavir 40%
• Hepatocellular Carcinoma 20%
• Liver Cirrhosis 20%
• Liver Function 20%
• Antiviral Therapy 20%
• Liver Histology 20%
• Decompensated Liver Cirrhosis 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Chronic Hepatitis B 100%
• Nucleoside 100%
• Tenofovir 40%
• Entecavir 40%
• Liver Cell Carcinoma 20%
• Liver Cirrhosis 20%
• Antiviral Therapy 20%
• Decompensated Liver Cirrhosis 20%